$FNWD
Finward Bancorp Stock $fnwd

$fnwd Overview Financials Valuation SEC Filings Company Website

2021 Q1 Form 10-Q Financial Statement

#000143774921011347 Filed on May 07, 2021

Income Statement

Concept	2021 Q1	2020 Q1
Revenue	$12.73M	$12.87M
YoY Change	-1.1%	3.06%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$1.040M	$1.050M
YoY Change	-0.95%	40.0%
% of Gross Profit
Operating Expenses
YoY Change
Operating Profit
YoY Change
Interest Expense	$681.0K	$2.198M
YoY Change	-69.02%	16.48%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income	$5.288M	$3.704M
YoY Change	42.76%	44.57%
Income Tax	$745.0K	$512.0K
% Of Pretax Income	14.09%	13.82%
Net Earnings	$4.543M	$3.113M
YoY Change	45.94%	40.1%
Net Earnings / Revenue	35.7%	24.19%
Basic Earnings Per Share	$1.31	$0.92
Diluted Earnings Per Share	$1.31	$0.92
COMMON SHARES
Basic Shares Outstanding	3.472M	3.459M
Diluted Shares Outstanding	3.472M	3.459M

Balance Sheet

Concept	2021 Q1	2020 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents	$68.01M	$42.15M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment	$30.56M	$28.93M
YoY Change	5.66%	3.56%
Goodwill	$11.10M	$11.11M
YoY Change	-0.08%	3.4%
Intangibles	$3.871M
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets
YoY Change
TOTAL ASSETS
Total Short-Term Assets
Total Long-Term Assets
Total Assets	$1.557B	$1.350B
YoY Change	15.32%	6.43%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses	$24.00M	$17.40M
YoY Change	37.93%	61.11%
Deferred Revenue
YoY Change
Short-Term Debt	$15.90M	$13.00M
YoY Change	22.31%	2.36%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$24.00M	$17.40M
YoY Change	37.93%	61.11%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00
YoY Change		-100.0%
Other Long-Term Liabilities		$3.300M
YoY Change
Total Long-Term Liabilities	$0.00	$3.300M
YoY Change	-100.0%	-83.5%
TOTAL LIABILITIES
Total Short-Term Liabilities	$24.00M	$17.40M
Total Long-Term Liabilities	$0.00	$3.300M
Total Liabilities	$1.407B	$1.209B
YoY Change	16.32%	5.6%
SHAREHOLDERS EQUITY
Retained Earnings	$116.1M	$102.3M
YoY Change	13.48%	9.39%
Common Stock	$30.07M	$29.67M
YoY Change	1.34%	0.6%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$148.8M	$133.5M
YoY Change
Total Liabilities & Shareholders Equity	$1.557B	$1.350B
YoY Change	15.32%	6.43%

Cashflow Statement

Concept	2021 Q1	2020 Q1
OPERATING ACTIVITIES
Net Income	$4.543M	$3.113M
YoY Change	45.94%	40.1%
Depreciation, Depletion And Amortization	$1.040M	$1.050M
YoY Change	-0.95%	40.0%
Cash From Operating Activities	$16.39M	$9.364M
YoY Change	75.07%	561.3%
INVESTING ACTIVITIES
Capital Expenditures	$379.0K	$200.0K
YoY Change	89.5%	354.55%
Acquisitions	$0.00
YoY Change
Other Investing Activities	-$27.35M	-$21.97M
YoY Change	24.49%	-158.65%
Cash From Investing Activities	-$27.58M	-$22.17M
YoY Change	24.39%	-159.26%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	$59.27M	$7.694M
YoY Change	670.34%	60.46%
NET CHANGE
Cash From Operating Activities	$16.39M	$9.364M
Cash From Investing Activities	-$27.58M	-$22.17M
Cash From Financing Activities	$59.27M	$7.694M
Net Change In Cash	$48.09M	-$5.112M
YoY Change	-1040.67%	-111.72%
FREE CASH FLOW
Cash From Operating Activities	$16.39M	$9.364M
Capital Expenditures	$379.0K	$200.0K
Free Cash Flow	$16.02M	$9.164M
YoY Change	74.76%	567.93%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2021Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	3477416
CY2021Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2020Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2021Q1	us-gaap	Preferred Stock No Par Value PreferredStockNoParValue	0
CY2020Q4	us-gaap	Preferred Stock No Par Value PreferredStockNoParValue	0
CY2021Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000
CY2020Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000
CY2021Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2020Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2021Q1	us-gaap	Common Stock No Par Value CommonStockNoParValue	0
CY2020Q4	us-gaap	Common Stock No Par Value CommonStockNoParValue	0
CY2021Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	10000000
CY2020Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	10000000
CY2021Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	3478921
CY2021Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	3478921
CY2020Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	3462916
CY2020Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	3462916
CY2020Q1	us-gaap	Stock Issued During Period Shares Restricted Stock Award Forfeited StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited	1904000
CY2020Q1	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.31
CY2021Q1	us-gaap	Stock Issued During Period Shares Restricted Stock Award Forfeited StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited	1711000
CY2021Q1	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.31
CY2021Q1	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	USD
CY2020Q4	us-gaap	Goodwill Goodwill	11100000	USD
CY2021Q1	us-gaap	Cash And Due From Banks CashAndDueFromBanks	14559000	USD
CY2020Q4	us-gaap	Cash And Due From Banks CashAndDueFromBanks	14014000	USD
CY2021Q1	us-gaap	Interest Bearing Deposits In Banks InterestBearingDepositsInBanks	52854000	USD
CY2020Q4	us-gaap	Interest Bearing Deposits In Banks InterestBearingDepositsInBanks	5908000	USD
CY2021Q1	us-gaap	Federal Funds Sold FederalFundsSold	596000	USD
CY2020Q4	us-gaap	Federal Funds Sold FederalFundsSold	0	USD
CY2021Q1	us-gaap	Cash Cash Equivalents And Federal Funds Sold CashCashEquivalentsAndFederalFundsSold	68009000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents And Federal Funds Sold CashCashEquivalentsAndFederalFundsSold	19922000	USD
CY2021Q1	us-gaap	Certificates Of Deposit At Carrying Value CertificatesOfDepositAtCarryingValue	1474000	USD
CY2020Q4	us-gaap	Certificates Of Deposit At Carrying Value CertificatesOfDepositAtCarryingValue	1897000	USD
CY2021Q1	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	422868000	USD
CY2020Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	410669000	USD
CY2021Q1	us-gaap	Loans Receivable Held For Sale Net Not Part Of Disposal Group LoansReceivableHeldForSaleNetNotPartOfDisposalGroup	4256000	USD
CY2020Q4	us-gaap	Loans Receivable Held For Sale Net Not Part Of Disposal Group LoansReceivableHeldForSaleNetNotPartOfDisposalGroup	11329000	USD
CY2021Q1	us-gaap	Loans And Leases Receivable Net Of Deferred Income LoansAndLeasesReceivableNetOfDeferredIncome	974054000	USD
CY2020Q4	us-gaap	Loans And Leases Receivable Net Of Deferred Income LoansAndLeasesReceivableNetOfDeferredIncome	966578000	USD
CY2021Q1	us-gaap	Loans And Leases Receivable Allowance LoansAndLeasesReceivableAllowance	13047000	USD
CY2020Q4	us-gaap	Loans And Leases Receivable Allowance LoansAndLeasesReceivableAllowance	12458000	USD
CY2021Q1	us-gaap	Loans And Leases Receivable Net Reported Amount LoansAndLeasesReceivableNetReportedAmount	961007000	USD
CY2020Q4	us-gaap	Loans And Leases Receivable Net Reported Amount LoansAndLeasesReceivableNetReportedAmount	954120000	USD
CY2021Q1	us-gaap	Federal Home Loan Bank Stock FederalHomeLoanBankStock	3918000	USD
CY2020Q4	us-gaap	Federal Home Loan Bank Stock FederalHomeLoanBankStock	3918000	USD
CY2021Q1	us-gaap	Interest Receivable InterestReceivable	4997000	USD
CY2020Q4	us-gaap	Interest Receivable InterestReceivable	4713000	USD
CY2021Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	30563000	USD
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	30785000	USD
CY2021Q1	us-gaap	Foreclosed Assets ForeclosedAssets	491000	USD
CY2020Q4	us-gaap	Foreclosed Assets ForeclosedAssets	538000	USD
CY2021Q1	us-gaap	Bank Owned Life Insurance BankOwnedLifeInsurance	30894000	USD
CY2020Q4	us-gaap	Bank Owned Life Insurance BankOwnedLifeInsurance	30725000	USD
CY2021Q1	us-gaap	Goodwill Goodwill	11109000	USD
CY2020Q4	us-gaap	Goodwill Goodwill	11109000	USD
CY2021Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	3871000	USD
CY2020Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	4119000	USD
CY2021Q1	us-gaap	Other Assets OtherAssets	13260000	USD
CY2020Q4	us-gaap	Other Assets OtherAssets	13681000	USD
CY2021Q1	us-gaap	Assets Assets	1556717000	USD
CY2020Q4	us-gaap	Assets Assets	1497525000	USD
CY2021Q1	us-gaap	Noninterest Bearing Deposit Liabilities NoninterestBearingDepositLiabilities	286969000	USD
CY2020Q4	us-gaap	Noninterest Bearing Deposit Liabilities NoninterestBearingDepositLiabilities	241620000	USD
CY2021Q1	us-gaap	Interest Bearing Deposit Liabilities InterestBearingDepositLiabilities	1079725000	USD
CY2020Q4	us-gaap	Interest Bearing Deposit Liabilities InterestBearingDepositLiabilities	1060719000	USD
CY2021Q1	us-gaap	Deposits Deposits	1366694000	USD
CY2020Q4	us-gaap	Deposits Deposits	1302339000	USD
CY2021Q1	us-gaap	Securities Sold Under Agreements To Repurchase SecuritiesSoldUnderAgreementsToRepurchase	15917000	USD
CY2020Q4	us-gaap	Securities Sold Under Agreements To Repurchase SecuritiesSoldUnderAgreementsToRepurchase	13711000	USD
CY2021Q1	us-gaap	Federal Home Loan Bank Advances Long Term FederalHomeLoanBankAdvancesLongTerm	0	USD
CY2020Q4	us-gaap	Federal Home Loan Bank Advances Long Term FederalHomeLoanBankAdvancesLongTerm	6149000	USD
CY2021Q1	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	23967000	USD
CY2020Q4	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	22404000	USD
CY2021Q1	us-gaap	Liabilities Liabilities	1406578000	USD
CY2020Q4	us-gaap	Liabilities Liabilities	1344603000	USD
CY2021Q1	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2020Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2021Q1	us-gaap	Common Stock Value CommonStockValue	0	USD
CY2020Q4	us-gaap	Common Stock Value CommonStockValue	0	USD
CY2021Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	30065000	USD
CY2020Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	29987000	USD
CY2021Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	3980000	USD
CY2020Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	10441000	USD
CY2021Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	116094000	USD
CY2020Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	112494000	USD
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	150139000	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	152922000	USD
CY2021Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1556717000	USD
CY2020Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1497525000	USD
CY2021Q1	us-gaap	Interest And Fee Income Loans Real Estate Construction InterestAndFeeIncomeLoansRealEstateConstruction	8239000	USD
CY2020Q1	us-gaap	Interest And Fee Income Loans Real Estate Construction InterestAndFeeIncomeLoansRealEstateConstruction	9357000	USD
CY2021Q1	us-gaap	Interest And Fee Income Loans Commercial Real Estate InterestAndFeeIncomeLoansCommercialRealEstate	2240000	USD
CY2020Q1	us-gaap	Interest And Fee Income Loans Commercial Real Estate InterestAndFeeIncomeLoansCommercialRealEstate	1485000	USD
CY2021Q1	us-gaap	Interest And Fee Income Loans Consumer InterestAndFeeIncomeLoansConsumer	267000	USD
CY2020Q1	us-gaap	Interest And Fee Income Loans Consumer InterestAndFeeIncomeLoansConsumer	187000	USD
CY2021Q1	us-gaap	Interest And Fee Income Loans And Leases Held In Portfolio InterestAndFeeIncomeLoansAndLeasesHeldInPortfolio	10746000	USD
CY2020Q1	us-gaap	Interest And Fee Income Loans And Leases Held In Portfolio InterestAndFeeIncomeLoansAndLeasesHeldInPortfolio	11029000	USD
CY2021Q1	us-gaap	Interest And Dividend Income Securities InterestAndDividendIncomeSecurities	1961000	USD
CY2020Q1	us-gaap	Interest And Dividend Income Securities InterestAndDividendIncomeSecurities	1705000	USD
CY2021Q1	us-gaap	Other Interest And Dividend Income OtherInterestAndDividendIncome	20000	USD
CY2020Q1	us-gaap	Other Interest And Dividend Income OtherInterestAndDividendIncome	135000	USD
CY2021Q1	us-gaap	Interest And Dividend Income Operating InterestAndDividendIncomeOperating	12727000	USD
CY2020Q1	us-gaap	Interest And Dividend Income Operating InterestAndDividendIncomeOperating	12869000	USD
CY2021Q1	us-gaap	Interest Expense Deposits InterestExpenseDeposits	651000	USD
CY2020Q1	us-gaap	Interest Expense Deposits InterestExpenseDeposits	2064000	USD
CY2021Q1	us-gaap	Repurchase Agreements Interest Expense Amount RepurchaseAgreementsInterestExpenseAmount	10000	USD
CY2020Q1	us-gaap	Repurchase Agreements Interest Expense Amount RepurchaseAgreementsInterestExpenseAmount	40000	USD
CY2021Q1	us-gaap	Interest Expense Borrowings InterestExpenseBorrowings	20000	USD
CY2020Q1	us-gaap	Interest Expense Borrowings InterestExpenseBorrowings	94000	USD
CY2021Q1	us-gaap	Interest Expense InterestExpense	681000	USD
CY2020Q1	us-gaap	Interest Expense InterestExpense	2198000	USD
CY2021Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	12046000	USD
CY2020Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	10671000	USD
CY2021Q1	us-gaap	Provision For Loan Losses Expensed ProvisionForLoanLossesExpensed	578000	USD
CY2020Q1	us-gaap	Provision For Loan Losses Expensed ProvisionForLoanLossesExpensed	514000	USD
CY2021Q1	us-gaap	Interest Income Expense After Provision For Loan Loss InterestIncomeExpenseAfterProvisionForLoanLoss	11468000	USD
CY2020Q1	us-gaap	Interest Income Expense After Provision For Loan Loss InterestIncomeExpenseAfterProvisionForLoanLoss	10157000	USD
CY2021Q1	nwin	Gain Loss On Sales Of Loans Including Derivative Net GainLossOnSalesOfLoansIncludingDerivativeNet	2049000	USD
CY2020Q1	nwin	Gain Loss On Sales Of Loans Including Derivative Net GainLossOnSalesOfLoansIncludingDerivativeNet	1153000	USD
CY2021Q1	nwin	Fees And Commission Depositor Accounts FeesAndCommissionDepositorAccounts	1066000	USD
CY2020Q1	nwin	Fees And Commission Depositor Accounts FeesAndCommissionDepositorAccounts	1049000	USD
CY2021Q1	nwin	Assets Management Income AssetsManagementIncome	607000	USD
CY2020Q1	nwin	Assets Management Income AssetsManagementIncome	554000	USD
CY2021Q1	us-gaap	Debt And Equity Securities Gain Loss DebtAndEquitySecuritiesGainLoss	417000	USD
CY2020Q1	us-gaap	Debt And Equity Securities Gain Loss DebtAndEquitySecuritiesGainLoss	510000	USD
CY2021Q1	us-gaap	Life Insurance Corporate Or Bank Owned Change In Value LifeInsuranceCorporateOrBankOwnedChangeInValue	169000	USD
CY2020Q1	us-gaap	Life Insurance Corporate Or Bank Owned Change In Value LifeInsuranceCorporateOrBankOwnedChangeInValue	169000	USD
CY2021Q1	us-gaap	Gains Losses On Sales Of Other Real Estate GainsLossesOnSalesOfOtherRealEstate	-9000	USD
CY2020Q1	us-gaap	Gains Losses On Sales Of Other Real Estate GainsLossesOnSalesOfOtherRealEstate	60000	USD
CY2021Q1	nwin	Other Noninterest Income Excluding Bank Owned Life Insurance Income OtherNoninterestIncomeExcludingBankOwnedLifeInsuranceIncome	14000	USD
CY2020Q1	nwin	Other Noninterest Income Excluding Bank Owned Life Insurance Income OtherNoninterestIncomeExcludingBankOwnedLifeInsuranceIncome	51000	USD
CY2021Q1	us-gaap	Noninterest Income NoninterestIncome	4313000	USD
CY2020Q1	us-gaap	Noninterest Income NoninterestIncome	3546000	USD
CY2021Q1	us-gaap	Labor And Related Expense LaborAndRelatedExpense	5530000	USD
CY2020Q1	us-gaap	Labor And Related Expense LaborAndRelatedExpense	5217000	USD
CY2021Q1	us-gaap	Occupancy Net OccupancyNet	1372000	USD
CY2020Q1	us-gaap	Occupancy Net OccupancyNet	1409000	USD
CY2021Q1	us-gaap	Information Technology And Data Processing InformationTechnologyAndDataProcessing	528000	USD
CY2020Q1	us-gaap	Information Technology And Data Processing InformationTechnologyAndDataProcessing	556000	USD
CY2021Q1	us-gaap	Marketing Expense MarketingExpense	199000	USD
CY2020Q1	us-gaap	Marketing Expense MarketingExpense	208000	USD
CY2021Q1	us-gaap	Federal Deposit Insurance Corporation Premium Expense FederalDepositInsuranceCorporationPremiumExpense	180000	USD
CY2020Q1	us-gaap	Federal Deposit Insurance Corporation Premium Expense FederalDepositInsuranceCorporationPremiumExpense	196000	USD
CY2021Q1	us-gaap	Other Noninterest Expense OtherNoninterestExpense	2529000	USD
CY2020Q1	us-gaap	Other Noninterest Expense OtherNoninterestExpense	2413000	USD
CY2021Q1	us-gaap	Noninterest Expense NoninterestExpense	10338000	USD
CY2020Q1	us-gaap	Noninterest Expense NoninterestExpense	9999000	USD
CY2021Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	5443000	USD
CY2020Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	3704000	USD
CY2021Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	764000	USD
CY2020Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	512000	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	4679000	USD
CY2021Q1	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax	-1717000	USD
CY2020Q1	us-gaap	Net Income Loss NetIncomeLoss	3192000	USD
CY2021Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.35
CY2020Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.92
CY2021Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.35
CY2020Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.92
CY2021Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.31
CY2020Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.31
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	4679000	USD
CY2020Q1	us-gaap	Net Income Loss NetIncomeLoss	3192000	USD
CY2021Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	-7761000	USD
CY2020Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	6112000	USD
CY2021Q1	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Before Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax	417000	USD
CY2020Q1	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Before Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax	510000	USD
CY2021Q1	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax	-8178000	USD
CY2020Q1	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax	5602000	USD
CY2020Q1	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax	1177000	USD
CY2021Q1	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	-6461000	USD
CY2020Q1	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	4425000	USD
CY2021Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-6461000	USD
CY2020Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	4425000	USD
CY2021Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-1782000	USD
CY2020Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	7617000	USD
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	134103000	USD
CY2020Q1	us-gaap	Net Income Loss NetIncomeLoss	3192000	USD
CY2020Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	4425000	USD
CY2020Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	7617000	USD
CY2020Q1	us-gaap	Restricted Stock Award Forfeitures RestrictedStockAwardForfeitures	85000	USD
CY2020Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	94000	USD
CY2020Q1	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	1074000	USD
CY2020Q1	us-gaap	Stockholders Equity StockholdersEquity	140655000	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	152922000	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	4679000	USD
CY2021Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-6461000	USD
CY2021Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-1782000	USD
CY2021Q1	us-gaap	Restricted Stock Award Forfeitures RestrictedStockAwardForfeitures	68000	USD
CY2021Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	146000	USD
CY2021Q1	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	1079000	USD
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	150139000	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	4679000	USD
CY2020Q1	us-gaap	Net Income Loss NetIncomeLoss	3192000	USD
CY2021Q1	us-gaap	Payments For Origination And Purchases Of Loans Held For Sale PaymentsForOriginationAndPurchasesOfLoansHeldForSale	49083000	USD
CY2020Q1	us-gaap	Payments For Origination And Purchases Of Loans Held For Sale PaymentsForOriginationAndPurchasesOfLoansHeldForSale	24870000	USD
CY2021Q1	us-gaap	Proceeds From Loans ProceedsFromLoans	57876000	USD
CY2020Q1	us-gaap	Proceeds From Loans ProceedsFromLoans	26197000	USD
CY2020Q1	us-gaap	Increase Decrease In Accrued Interest Receivable Net IncreaseDecreaseInAccruedInterestReceivableNet	85000	USD
CY2021Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-2662000	USD
CY2020Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	637000	USD
CY2021Q1	nwin	Increase Decrease In Cash Surrender Value Of Bank Owned Life Insurance IncreaseDecreaseInCashSurrenderValueOfBankOwnedLifeInsurance	169000	USD
CY2020Q1	nwin	Increase Decrease In Cash Surrender Value Of Bank Owned Life Insurance IncreaseDecreaseInCashSurrenderValueOfBankOwnedLifeInsurance	169000	USD
CY2021Q1	us-gaap	Depreciation Amortization And Accretion Net DepreciationAmortizationAndAccretionNet	990000	USD
CY2020Q1	us-gaap	Depreciation Amortization And Accretion Net DepreciationAmortizationAndAccretionNet	1039000	USD
CY2021Q1	us-gaap	Amortization Of Mortgage Servicing Rights Ms Rs AmortizationOfMortgageServicingRightsMSRs	53000	USD
CY2020Q1	us-gaap	Amortization Of Mortgage Servicing Rights Ms Rs AmortizationOfMortgageServicingRightsMSRs	12000	USD
CY2021Q1	us-gaap	Share Based Compensation ShareBasedCompensation	146000	USD
CY2020Q1	us-gaap	Share Based Compensation ShareBasedCompensation	94000	USD
CY2021Q1	nwin	Net Surrender Value Of Restricted Stock Awards NetSurrenderValueOfRestrictedStockAwards	68000	USD
CY2020Q1	nwin	Net Surrender Value Of Restricted Stock Awards NetSurrenderValueOfRestrictedStockAwards	85000	USD
CY2021Q1	us-gaap	Debt And Equity Securities Gain Loss DebtAndEquitySecuritiesGainLoss	417000	USD
CY2020Q1	us-gaap	Debt And Equity Securities Gain Loss DebtAndEquitySecuritiesGainLoss	510000	USD
CY2021Q1	us-gaap	Gain Loss On Sales Of Loans Net GainLossOnSalesOfLoansNet	2026000	USD
CY2020Q1	us-gaap	Gain Loss On Sales Of Loans Net GainLossOnSalesOfLoansNet	635000	USD
CY2021Q1	us-gaap	Gain Loss On Sale Of Derivatives GainLossOnSaleOfDerivatives	23000	USD
CY2020Q1	us-gaap	Gain Loss On Sale Of Derivatives GainLossOnSaleOfDerivatives	518000	USD
CY2021Q1	us-gaap	Gains Losses On Sales Of Other Real Estate GainsLossesOnSalesOfOtherRealEstate	-9000	USD
CY2020Q1	us-gaap	Gains Losses On Sales Of Other Real Estate GainsLossesOnSalesOfOtherRealEstate	60000	USD
CY2021Q1	us-gaap	Provision For Loan Losses Expensed ProvisionForLoanLossesExpensed	578000	USD
CY2020Q1	us-gaap	Provision For Loan Losses Expensed ProvisionForLoanLossesExpensed	514000	USD
CY2021Q1	us-gaap	Increase Decrease In Accrued Interest Receivable Net IncreaseDecreaseInAccruedInterestReceivableNet	284000	USD
CY2021Q1	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	1558000	USD
CY2020Q1	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	5885000	USD
CY2021Q1	us-gaap	Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities	11802000	USD
CY2020Q1	us-gaap	Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities	6172000	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	16481000	USD
CY2020Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	9364000	USD
CY2021Q1	nwin	Payments For Proceeds From Certificates Of Deposit In Other Financial Institutions PaymentsForProceedsFromCertificatesOfDepositInOtherFinancialInstitutions	-423000	USD
CY2020Q1	nwin	Payments For Proceeds From Certificates Of Deposit In Other Financial Institutions PaymentsForProceedsFromCertificatesOfDepositInOtherFinancialInstitutions	-429000	USD
CY2021Q1	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	27287000	USD
CY2020Q1	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	16671000	USD
CY2021Q1	us-gaap	Proceeds From Sale Of Available For Sale Securities ProceedsFromSaleOfAvailableForSaleSecurities	6904000	USD
CY2020Q1	us-gaap	Proceeds From Sale Of Available For Sale Securities ProceedsFromSaleOfAvailableForSaleSecurities	17886000	USD
CY2021Q1	us-gaap	Payments To Acquire Available For Sale Securities PaymentsToAcquireAvailableForSaleSecurities	54540000	USD
CY2020Q1	us-gaap	Payments To Acquire Available For Sale Securities PaymentsToAcquireAvailableForSaleSecurities	44972000	USD
CY2021Q1	us-gaap	Payments For Proceeds From Loans And Leases PaymentsForProceedsFromLoansAndLeases	4486000	USD
CY2020Q1	us-gaap	Payments For Proceeds From Loans And Leases PaymentsForProceedsFromLoansAndLeases	12118000	USD
CY2021Q1	us-gaap	Payments To Acquire Loans Receivable PaymentsToAcquireLoansReceivable	2989000	USD
CY2020Q1	us-gaap	Payments To Acquire Loans Receivable PaymentsToAcquireLoansReceivable	-0	USD
CY2021Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	379000	USD
CY2020Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	200000	USD
CY2021Q1	us-gaap	Proceeds From Sale Of Foreclosed Assets ProceedsFromSaleOfForeclosedAssets	48000	USD
CY2020Q1	us-gaap	Proceeds From Sale Of Foreclosed Assets ProceedsFromSaleOfForeclosedAssets	134000	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-27732000	USD
CY2020Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-22170000	USD
CY2021Q1	us-gaap	Increase Decrease In Deposits IncreaseDecreaseInDeposits	64355000	USD
CY2020Q1	us-gaap	Increase Decrease In Deposits IncreaseDecreaseInDeposits	7272000	USD
CY2021Q1	us-gaap	Repayments Of Federal Home Loan Bank Borrowings RepaymentsOfFederalHomeLoanBankBorrowings	6000000	USD
CY2020Q1	us-gaap	Repayments Of Federal Home Loan Bank Borrowings RepaymentsOfFederalHomeLoanBankBorrowings	-0	USD
CY2021Q1	us-gaap	Proceeds From Repayments Of Other Debt ProceedsFromRepaymentsOfOtherDebt	2057000	USD
CY2020Q1	us-gaap	Proceeds From Repayments Of Other Debt ProceedsFromRepaymentsOfOtherDebt	1492000	USD
CY2020Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-5112000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	19922000	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	47258000	USD
CY2021Q1	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	1074000	USD
CY2020Q1	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	1070000	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	59338000	USD
CY2020Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	7694000	USD
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	48087000	USD
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	68009000	USD
CY2020Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	42146000	USD
CY2021Q1	us-gaap	Interest Paid Net InterestPaidNet	690000	USD
CY2020Q1	us-gaap	Interest Paid Net InterestPaidNet	2283000	USD
CY2021Q1	nwin	Transfers From Loans To Foreclosed Real Estate TransfersFromLoansToForeclosedRealEstate	0	USD
CY2020Q1	nwin	Transfers From Loans To Foreclosed Real Estate TransfersFromLoansToForeclosedRealEstate	23000	USD
CY2021Q1	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	1079000	USD
CY2020Q1	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	1074000	USD
CY2021Q1	us-gaap	Basis Of Accounting BasisOfAccounting	<p style="font-family: Arial; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>Note <em style="font: inherit;">1</em> - Basis of Presentation</b></p> <p style="font-family: Arial; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 18pt;">The consolidated financial statements include the accounts of NorthWest Indiana Bancorp (the “Bancorp” or “NWIN”), its wholly-owned subsidiaries NWIN Risk Management, Inc. (a captive insurance subsidiary) and Peoples Bank (the “Bank”), and the Bank’s wholly-owned subsidiaries, Peoples Service Corporation, NWIN, LLC, NWIN Funding, Incorporated, and Columbia Development Company, LLC. The Bancorp’s business activities include being a holding company for the Bank as well as a holding company for NWIN Risk Management, Inc. The Bancorp’s earnings are primarily dependent upon the earnings of the Bank. The accompanying unaudited consolidated financial statements were prepared in accordance with instructions for Form <em style="font: inherit;">10</em>-Q and, therefore, do <em style="font: inherit;">not</em> include all disclosures required by U.S. generally accepted accounting principles for complete presentation of consolidated financial statements. In the opinion of management, the consolidated financial statements contain all adjustments necessary to present fairly the consolidated balance sheets of the Bancorp as of <em style="font: inherit;"> March 31, 2021, </em>and <em style="font: inherit;"> December 31, 2020, </em>and the consolidated statements of income, comprehensive income, changes in stockholders’ equity, and consolidated statements of cash flows for the <em style="font: inherit;">three</em> months ended <em style="font: inherit;"> March 31, 2021, </em>and <em style="font: inherit;">2020.</em> The income reported for the <em style="font: inherit;">three</em> month period ended <em style="font: inherit;"> March 31, 2021, </em>is <em style="font: inherit;">not</em> necessarily indicative of the results to be expected for the full year.</p> <p style="font-family: Arial; font-size: 10pt; font-variant: normal; margin: 0pt;"> </p> <p style="font-family: Arial; font-size: 10pt; font-variant: normal; margin: 0pt;">The Notes to the Consolidated Financial Statements appearing in NorthWest Indiana Bancorp’s Annual Report on Form <em style="font: inherit;">10</em>-K (<em style="font: inherit;">2020</em> Annual Report), which include descriptions of significant accounting policies, should be read in conjunction with these interim financial statements. The Consolidated Balance Sheet at <em style="font: inherit;"> December 31, 2020 </em>has been derived from the audited financial statements at that date but does <em style="font: inherit;">not</em> include all of the information and footnotes required by GAAP for complete financial statements. Certain amounts in the prior period consolidated financial statements have been reclassified to conform to the current period presentation. These reclassifications had <em style="font: inherit;">no</em> effect on net income.</p>
CY2021Q1	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	417839000	USD
CY2021Q1	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	10417000	USD
CY2021Q1	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	5388000	USD
CY2021Q1	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	422868000	USD
CY2020Q4	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	397462000	USD
CY2020Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	14522000	USD
CY2020Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	1315000	USD
CY2020Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	410669000	USD
CY2021Q1	us-gaap	Available For Sale Securities Debt Maturities Within One Year Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue	202000	USD
CY2021Q1	nwin	Available For Sale Securities Debt Maturities Within One Year Tax Equivalent Yield Rate AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearTaxEquivalentYieldRate	0.0113	pure
CY2021Q1	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue	3787000	USD
CY2021Q1	nwin	Available For Sale Securities Debt Maturities After One Through Five Years Tax Equivalent Yield Rate AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsTaxEquivalentYieldRate	0.0444	pure
CY2021Q1	us-gaap	Available For Sale Securities Debt Maturities After Five Through Ten Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue	29327000	USD
CY2021Q1	nwin	Available For Sale Securities Debt Maturities After Five Through Ten Years Tax Equivalent Yield Rate AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsTaxEquivalentYieldRate	0.0248	pure
CY2021Q1	us-gaap	Available For Sale Securities Debt Maturities After Ten Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue	201430000	USD
CY2021Q1	nwin	Available For Sale Securities Debt Maturities After Ten Years Tax Equivalent Yield Rate AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsTaxEquivalentYieldRate	0.0318	pure
CY2021Q1	us-gaap	Available For Sale Securities Debt Maturities Without Single Maturity Date Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue	188122000	USD
CY2021Q1	nwin	Available For Sale Securities Debt Without A Single Maturity Date Tax Equivalent Yield Rate AvailableForSaleSecuritiesDebtWithoutASingleMaturityDateTaxEquivalentYieldRate	0.0180	pure
CY2021Q1	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	422868000	USD
CY2021Q1	nwin	Available For Sale Securities Tax Equivalent Yield Rate AvailableForSaleSecuritiesTaxEquivalentYieldRate	0.0253	pure
CY2021Q1	us-gaap	Proceeds From Sale Of Available For Sale Securities ProceedsFromSaleOfAvailableForSaleSecurities	6904000	USD
CY2020Q1	us-gaap	Proceeds From Sale Of Available For Sale Securities ProceedsFromSaleOfAvailableForSaleSecurities	17886000	USD
CY2021Q1	us-gaap	Available For Sale Securities Gross Realized Gains AvailableForSaleSecuritiesGrossRealizedGains	417000	USD
CY2020Q1	us-gaap	Available For Sale Securities Gross Realized Gains AvailableForSaleSecuritiesGrossRealizedGains	513000	USD
CY2021Q1	us-gaap	Available For Sale Securities Gross Realized Losses AvailableForSaleSecuritiesGrossRealizedLosses	-0	USD
CY2020Q1	us-gaap	Available For Sale Securities Gross Realized Losses AvailableForSaleSecuritiesGrossRealizedLosses	3000	USD
CY2020Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	10441000	USD
CY2021Q1	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	-6461000	USD
CY2021Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	3980000	USD
CY2021Q1	us-gaap	Security Owned And Pledged As Collateral Fair Value SecurityOwnedAndPledgedAsCollateralFairValue	47700000	USD
CY2020Q4	us-gaap	Security Owned And Pledged As Collateral Fair Value SecurityOwnedAndPledgedAsCollateralFairValue	52400000	USD
CY2021Q1	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue	181527000	USD
CY2021Q1	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss	4155000	USD
CY2021Q1	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Twelve Months Or Longer Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue	944000	USD
CY2021Q1	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss	1233000	USD
CY2021Q1	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValue	182471000	USD
CY2021Q1	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Accumulated Loss AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLoss	5388000	USD
CY2021Q1	us-gaap	Available For Sale Securities In Unrealized Loss Positions Qualitative Disclosure Number Of Positions Less Than One Year AvailableForSaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsLessThanOneYear	126	pure
CY2021Q1	us-gaap	Availableforsale Securities In Unrealized Loss Positions Qualitative Disclosure Number Of Positions Greater Than Or Equal To One Year AvailableforsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsGreaterThanOrEqualToOneYear	2	pure
CY2021Q1	us-gaap	Availableforsale Securities In Unrealized Loss Positions Qualitative Disclosure Number Of Positions1 AvailableforsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositions1	128	pure
CY2020Q4	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue	18792000	USD
CY2020Q4	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss	62000	USD
CY2020Q4	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Twelve Months Or Longer Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue	929000	USD
CY2020Q4	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss	1253000	USD
CY2020Q4	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValue	19721000	USD
CY2020Q4	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Accumulated Loss AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLoss	1315000	USD
CY2020Q4	us-gaap	Available For Sale Securities In Unrealized Loss Positions Qualitative Disclosure Number Of Positions Less Than One Year AvailableForSaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsLessThanOneYear	8	pure
CY2020Q4	us-gaap	Availableforsale Securities In Unrealized Loss Positions Qualitative Disclosure Number Of Positions Greater Than Or Equal To One Year AvailableforsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsGreaterThanOrEqualToOneYear	2	pure
CY2020Q4	us-gaap	Availableforsale Securities In Unrealized Loss Positions Qualitative Disclosure Number Of Positions1 AvailableforsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositions1	10	pure
CY2021Q1	us-gaap	Financing Receivable Recorded Investment Current FinancingReceivableRecordedInvestmentCurrent	963187000	USD
CY2021Q1	us-gaap	Loans And Leases Receivable Net Of Deferred Income LoansAndLeasesReceivableNetOfDeferredIncome	974054000	USD
CY2021Q1	us-gaap	Financing Receivable Recorded Investment90 Days Past Due And Still Accruing FinancingReceivableRecordedInvestment90DaysPastDueAndStillAccruing	599000	USD
CY2020Q4	us-gaap	Financing Receivable Recorded Investment Past Due FinancingReceivableRecordedInvestmentPastDue	15304000	USD
CY2020Q4	us-gaap	Financing Receivable Recorded Investment Current FinancingReceivableRecordedInvestmentCurrent	951274000	USD
CY2020Q4	us-gaap	Loans And Leases Receivable Net Of Deferred Income LoansAndLeasesReceivableNetOfDeferredIncome	966578000	USD
CY2020Q4	us-gaap	Financing Receivable Recorded Investment90 Days Past Due And Still Accruing FinancingReceivableRecordedInvestment90DaysPastDueAndStillAccruing	566000	USD
CY2021Q1	us-gaap	Mortgage Loans On Real Estate MortgageLoansOnRealEstate	767449000	USD
CY2020Q4	us-gaap	Mortgage Loans On Real Estate MortgageLoansOnRealEstate	767886000	USD
CY2021Q1	us-gaap	Loans And Leases Receivable Before Fees Gross LoansAndLeasesReceivableBeforeFeesGross	967415000	USD
CY2020Q4	us-gaap	Loans And Leases Receivable Before Fees Gross LoansAndLeasesReceivableBeforeFeesGross	961425000	USD
CY2021Q1	us-gaap	Unamortized Loan Commitment And Origination Fees And Unamortized Discounts Or Premiums UnamortizedLoanCommitmentAndOriginationFeesAndUnamortizedDiscountsOrPremiums	5673000	USD
CY2020Q4	us-gaap	Unamortized Loan Commitment And Origination Fees And Unamortized Discounts Or Premiums UnamortizedLoanCommitmentAndOriginationFeesAndUnamortizedDiscountsOrPremiums	5303000	USD
CY2021Q1	nwin	Loans And Leases Receivable Loans In Process Increase Reduction LoansAndLeasesReceivableLoansInProcessIncreaseReduction	-966000	USD
CY2020Q4	nwin	Loans And Leases Receivable Loans In Process Increase Reduction LoansAndLeasesReceivableLoansInProcessIncreaseReduction	150000	USD
CY2021Q1	us-gaap	Loans And Leases Receivable Net Of Deferred Income LoansAndLeasesReceivableNetOfDeferredIncome	974054000	USD
CY2020Q4	us-gaap	Loans And Leases Receivable Net Of Deferred Income LoansAndLeasesReceivableNetOfDeferredIncome	966578000	USD
CY2020Q4	us-gaap	Loans And Leases Receivable Allowance LoansAndLeasesReceivableAllowance	12458000	USD
CY2021Q1	us-gaap	Allowance For Loan And Lease Losses Write Offs AllowanceForLoanAndLeaseLossesWriteOffs	11000	USD
CY2021Q1	us-gaap	Allowance For Loan And Lease Loss Recovery Of Bad Debts AllowanceForLoanAndLeaseLossRecoveryOfBadDebts	22000	USD
CY2021Q1	us-gaap	Provision For Loan And Lease Losses ProvisionForLoanAndLeaseLosses	578000	USD
CY2021Q1	us-gaap	Loans And Leases Receivable Allowance LoansAndLeasesReceivableAllowance	13047000	USD
CY2019Q4	us-gaap	Loans And Leases Receivable Allowance LoansAndLeasesReceivableAllowance	8999000	USD
CY2020Q1	us-gaap	Allowance For Loan And Lease Losses Write Offs AllowanceForLoanAndLeaseLossesWriteOffs	12000	USD
CY2020Q1	us-gaap	Allowance For Loan And Lease Loss Recovery Of Bad Debts AllowanceForLoanAndLeaseLossRecoveryOfBadDebts	10000	USD
CY2020Q1	us-gaap	Provision For Loan And Lease Losses ProvisionForLoanAndLeaseLosses	514000	USD
CY2020Q1	us-gaap	Loans And Leases Receivable Allowance LoansAndLeasesReceivableAllowance	9511000	USD
CY2021Q1	us-gaap	Financing Receivable Allowance For Credit Losses Individually Evaluated For Impairment1 FinancingReceivableAllowanceForCreditLossesIndividuallyEvaluatedForImpairment1	1884000	USD
CY2021Q1	us-gaap	Financing Receivable Allowance For Credit Losses Collectively Evaluated For Impairment FinancingReceivableAllowanceForCreditLossesCollectivelyEvaluatedForImpairment	11163000	USD
CY2021Q1	us-gaap	Loans And Leases Receivable Net Of Deferred Income LoansAndLeasesReceivableNetOfDeferredIncome	974054000	USD
CY2021Q1	us-gaap	Financing Receivable Individually Evaluated For Impairment FinancingReceivableIndividuallyEvaluatedForImpairment	8998000	USD
CY2021Q1	nwin	Financing Receivable Purchased Credit Impaired Individually Evaluated For Impairment FinancingReceivablePurchasedCreditImpairedIndividuallyEvaluatedForImpairment	3220000	USD
CY2021Q1	us-gaap	Financing Receivable Collectively Evaluated For Impairment FinancingReceivableCollectivelyEvaluatedForImpairment	961836000	USD
CY2020Q4	us-gaap	Financing Receivable Allowance For Credit Losses Individually Evaluated For Impairment1 FinancingReceivableAllowanceForCreditLossesIndividuallyEvaluatedForImpairment1	1775000	USD
CY2020Q4	us-gaap	Financing Receivable Allowance For Credit Losses Collectively Evaluated For Impairment FinancingReceivableAllowanceForCreditLossesCollectivelyEvaluatedForImpairment	10683000	USD
CY2020Q4	us-gaap	Loans And Leases Receivable Net Of Deferred Income LoansAndLeasesReceivableNetOfDeferredIncome	966578000	USD
CY2020Q4	us-gaap	Financing Receivable Individually Evaluated For Impairment FinancingReceivableIndividuallyEvaluatedForImpairment	8455000	USD
CY2020Q4	nwin	Financing Receivable Purchased Credit Impaired Individually Evaluated For Impairment FinancingReceivablePurchasedCreditImpairedIndividuallyEvaluatedForImpairment	3366000	USD
CY2020Q4	us-gaap	Financing Receivable Collectively Evaluated For Impairment FinancingReceivableCollectivelyEvaluatedForImpairment	954757000	USD
CY2021Q1	us-gaap	Notes Receivable Net NotesReceivableNet	974054000	USD
CY2020Q4	us-gaap	Notes Receivable Net NotesReceivableNet	966578000	USD
CY2021Q1	us-gaap	Financing Receivable Recorded Investment Past Due FinancingReceivableRecordedInvestmentPastDue	10867000	USD
CY2021Q1	us-gaap	Financing Receivable Recorded Investment Nonaccrual Status FinancingReceivableRecordedInvestmentNonaccrualStatus	12257000	USD
CY2020Q4	us-gaap	Financing Receivable Recorded Investment Nonaccrual Status FinancingReceivableRecordedInvestmentNonaccrualStatus	13799000	USD
CY2021Q1	nwin	Financing Receivables Acquired Accretableyield Amount Collected Previous Year FinancingReceivablesAcquiredAccretableyieldAmountCollectedPreviousYear	360000	USD
CY2021Q1	nwin	Financing Receivables Acquired Accretable Yield Collected Current Year FinancingReceivablesAcquiredAccretableYieldCollectedCurrentYear	305000	USD
CY2021Q1	nwin	Financing Receivables Acquired Accretable Yield To Be Collected Remainder Of Fiscal Year FinancingReceivablesAcquiredAccretableYieldToBeCollectedRemainderOfFiscalYear	614000	USD
CY2021Q1	nwin	Financing Receivables Acquired Accretable Yield To Be Collected Year One FinancingReceivablesAcquiredAccretableYieldToBeCollectedYearOne	810000	USD
CY2021Q1	nwin	Financing Receivables Acquired Accretable Yield To Be Collected Year Two FinancingReceivablesAcquiredAccretableYieldToBeCollectedYearTwo	289000	USD
CY2021Q1	nwin	Financing Receivables Acquired Accretable Yield To Be Collected FinancingReceivablesAcquiredAccretableYieldToBeCollected	1713000	USD
CY2021Q1	us-gaap	Foreclosed Assets ForeclosedAssets	491000	USD
CY2020Q4	us-gaap	Foreclosed Assets ForeclosedAssets	538000	USD
CY2021Q1	us-gaap	Goodwill Goodwill	11100000	USD
CY2020	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	USD
CY2021Q1	us-gaap	Goodwill Goodwill	11100000	USD
CY2021Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	248000	USD
CY2021Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	746000	USD
CY2021Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	983000	USD
CY2021Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	962000	USD
CY2021Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	919000	USD
CY2021Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	261000	USD
CY2021Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	3871000	USD
CY2021Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	4679000	USD
CY2020Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	3192000	USD
CY2021Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	3471604
CY2020Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	3458505
CY2021Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.35
CY2020Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.92
CY2021Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	4679000	USD
CY2020Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	3192000	USD
CY2021Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	3471604
CY2020Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	3458505
CY2021Q1	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0
CY2020Q1	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0
CY2021Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	3471604
CY2020Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	3458505
CY2021Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.35
CY2020Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.92
CY2021Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	146000	USD
CY2020Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	94000	USD
CY2021Q1	nwin	Share Based Compensation Expense Estimated Future Compensation Total ShareBasedCompensationExpenseEstimatedFutureCompensationTotal	1100000	USD
CY2021Q1	nwin	Share Based Compensation Expense Estimated For Remainder Of Fiscal Year ShareBasedCompensationExpenseEstimatedForRemainderOfFiscalYear	407000	USD
CY2021Q1	nwin	Share Based Compensation Expense Estimated For Year One ShareBasedCompensationExpenseEstimatedForYearOne	435000	USD
CY2021Q1	nwin	Share Based Compensation Expense Estimated For Year Two ShareBasedCompensationExpenseEstimatedForYearTwo	262000	USD
CY2021Q1	nwin	Share Based Compensation Expense Estimated For Year Three ShareBasedCompensationExpenseEstimatedForYearThree	38000	USD
CY2019Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	30205
CY2019Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	35.63
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	13243
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	44.30
CY2020	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares	6400
CY2020	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue	27.50
CY2020	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares	220
CY2020	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue	43.65
CY2020Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	36828
CY2020Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	40.11
CY2020Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	36828
CY2020Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	40.11
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	17716
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	40.50
CY2021Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares	9993
CY2021Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue	36.71
CY2021Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares	-0
CY2021Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue	0
CY2021Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	44551
CY2021Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	41.03
CY2020Q4	us-gaap	Derivative Fair Value Amount Offset Against Collateral Net DerivativeFairValueAmountOffsetAgainstCollateralNet	4012000	USD
CY2021Q1	us-gaap	Derivative Fair Value Of Derivative Liability DerivativeFairValueOfDerivativeLiability	3391000	USD
CY2021Q1	us-gaap	Derivative Liability Fair Value Gross Asset DerivativeLiabilityFairValueGrossAsset	0	USD
CY2021Q1	us-gaap	Derivative Liabilities DerivativeLiabilities	3391000	USD
CY2021Q1	us-gaap	Derivative Collateral Right To Reclaim Securities DerivativeCollateralRightToReclaimSecurities	0	USD
CY2021Q1	us-gaap	Derivative Collateral Right To Reclaim Cash DerivativeCollateralRightToReclaimCash	3930000	USD
CY2021Q1	us-gaap	Derivative Fair Value Of Derivative Liability Amount Offset Against Collateral DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral	539000	USD
CY2021Q1	us-gaap	Description Of New Accounting Pronouncements Not Yet Adopted DescriptionOfNewAccountingPronouncementsNotYetAdopted	<p style="font-family: Arial; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>Note <em style="font: inherit;">11</em> - Upcoming Accounting Standards</b></p> <p style="font-family: Arial; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 18pt;">In <em style="font: inherit;"> June 2016, </em>FASB issued ASU <em style="font: inherit;">No.</em> <em style="font: inherit;">2016</em>-<em style="font: inherit;">13,</em> Financial Instruments - Credit Losses: Measurement of Credit Losses on Financial Instruments. The ASU includes increased disclosures and various changes to the accounting and measurement of financial assets including the Bancorp’s loans and available-for-sale debt securities. Each financial asset presented on the balance sheet would have a unique allowance for credit losses valuation account that is deducted from the amortized cost basis to present the net carrying value at the amount expected to be collected on the financial asset. The amendments in this ASU also eliminate the probable initial recognition threshold in current GAAP and instead, reflect an entity’s current estimate of all expected credit losses using reasonable and supportable forecasts. In <em style="font: inherit;"> October 2019, </em>the FASB voted and approved proposed changes to the effective date of this ASU for smaller reporting companies, such as the Bancorp, and other non-SEC reporting entities. The approval changed the effective date of the ASU to fiscal years beginning after <em style="font: inherit;"> December 15, 2022, </em>including interim periods within those fiscal periods. The new credit loss guidance will be effective for the Bancorp's year ending <em style="font: inherit;"> December 31, 2023. </em>Upon adoption, the ASU will be applied using a modified retrospective transition method to the beginning of the <em style="font: inherit;">first</em> reporting period in which the guidance is effective. A prospective transition approach is required for debt securities for which an other-than-temporary impairment had been recognized before the effective date. Early adoption for all institutions is permitted for fiscal years beginning after <em style="font: inherit;"> December 15, 2018, </em>including interim periods within those fiscal years. Management is in the process of evaluating the impact adoption of this update will have on the Bancorp’s consolidated financial statements. This process of evaluation has engaged multiple areas of the Bancorp’s management in discussing loss estimation methods and the application of these methods to specific segments of the loans receivable portfolio. Management has been actively monitoring developments and evaluating the use of different methods allowed. Due to continuing development of understanding of application, additional time is required to understand how this ASU will affect the Bancorp’s financial statements. Management plans on running parallel calculations and finalizing a method or methods of adoption in time for the effective date.</p> <p style="font-family: Arial; font-size: 10pt; font-variant: normal; margin: 0pt;"> </p> <p style="font-family: Arial; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 18pt;">In <em style="font: inherit;"> March 2020, </em>the FASB issued ASU <em style="font: inherit;">No.</em> <em style="font: inherit;">2020</em>-<em style="font: inherit;">04</em> “Reference Rate Reform (Topic <em style="font: inherit;">848</em>): Facilitation of the Effects of Reference Rate Reform on Financial Reporting.” These amendments provide temporary optional guidance to ease the potential burden in accounting for reference rate reform. The ASU provides optional expedients and exceptions for applying generally accepted accounting principles to contract modifications and hedging relationships, subject to meeting certain criteria, that reference LIBOR or another reference rate expected to be discontinued. It is intended to help stakeholders during the global market-wide reference rate transition period. In <em style="font: inherit;"> January 2021, </em>the FASB issued ASU <em style="font: inherit;">2021</em>-<em style="font: inherit;">01</em> which clarifies that certain optional expedients and exceptions in Topic <em style="font: inherit;">848</em> for contract modifications and hedge accounting apply to derivatives that are affected by the discounting transition. The guidance is effective for all entities as of <em style="font: inherit;"> March 12, 2020, </em>through <em style="font: inherit;"> December 31, 2022. </em>The Bancorp is implementing a transition plan to identify and modify its loans and other financial instruments with attributes that are either directly or indirectly influenced by LIBOR. The Bancorp is continuing to assess ASU <em style="font: inherit;">2020</em>-<em style="font: inherit;">04</em> and its impact on the Bancorp’s transition away from LIBOR for its loan and other financial instruments.</p>
CY2021Q1	us-gaap	Derivative Instruments Not Designated As Hedging Instruments Asset At Fair Value DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue	3788000	USD
CY2021Q1	us-gaap	Derivative Instruments Not Designated As Hedging Instruments Liability At Fair Value DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue	3391000	USD
CY2020Q4	us-gaap	Derivative Instruments Not Designated As Hedging Instruments Asset At Fair Value DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue	4012000	USD
CY2020Q4	us-gaap	Derivative Instruments Not Designated As Hedging Instruments Liability At Fair Value DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue	3638000	USD
CY2021Q1	us-gaap	Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet	10000	USD
CY2020Q1	us-gaap	Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet	518000	USD
CY2021Q1	us-gaap	Derivative Fair Value Of Derivative Asset DerivativeFairValueOfDerivativeAsset	3788000	USD
CY2021Q1	us-gaap	Derivative Asset Fair Value Gross Liability DerivativeAssetFairValueGrossLiability	0	USD
CY2021Q1	us-gaap	Derivative Assets DerivativeAssets	3788000	USD
CY2021Q1	us-gaap	Derivative Collateral Obligation To Return Securities DerivativeCollateralObligationToReturnSecurities	0	USD
CY2021Q1	us-gaap	Derivative Collateral Obligation To Return Cash DerivativeCollateralObligationToReturnCash	0	USD
CY2021Q1	us-gaap	Derivative Fair Value Amount Offset Against Collateral Net DerivativeFairValueAmountOffsetAgainstCollateralNet	3788000	USD
CY2020Q4	us-gaap	Derivative Fair Value Of Derivative Asset DerivativeFairValueOfDerivativeAsset	4012000	USD
CY2020Q4	us-gaap	Derivative Asset Fair Value Gross Liability DerivativeAssetFairValueGrossLiability	0	USD
CY2020Q4	us-gaap	Derivative Assets DerivativeAssets	4012000	USD
CY2020Q4	us-gaap	Derivative Collateral Obligation To Return Securities DerivativeCollateralObligationToReturnSecurities	0	USD
CY2020Q4	us-gaap	Derivative Collateral Obligation To Return Cash DerivativeCollateralObligationToReturnCash	0	USD
CY2020Q4	us-gaap	Derivative Fair Value Of Derivative Liability DerivativeFairValueOfDerivativeLiability	3638000	USD
CY2020Q4	us-gaap	Derivative Liability Fair Value Gross Asset DerivativeLiabilityFairValueGrossAsset	0	USD
CY2020Q4	us-gaap	Derivative Liabilities DerivativeLiabilities	3638000	USD
CY2020Q4	us-gaap	Derivative Collateral Right To Reclaim Securities DerivativeCollateralRightToReclaimSecurities	0	USD
CY2020Q4	us-gaap	Derivative Collateral Right To Reclaim Cash DerivativeCollateralRightToReclaimCash	3930000	USD
CY2020Q4	us-gaap	Derivative Liability Not Offset Policy Election Deduction DerivativeLiabilityNotOffsetPolicyElectionDeduction	292000	USD
CY2020	us-gaap	Other Than Temporary Impairment Credit Losses Recognized In Earnings Additions Additional Credit Losses OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsAdditionsAdditionalCreditLosses	0	USD
CY2020Q4	us-gaap	Other Than Temporary Impairment Credit Losses Recognized In Earnings Credit Losses On Debt Securities Held OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCreditLossesOnDebtSecuritiesHeld	173000	USD
CY2021Q1	us-gaap	Other Than Temporary Impairment Credit Losses Recognized In Earnings Additions No Previous Impairment OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsAdditionsNoPreviousImpairment	0	USD
CY2021Q1	us-gaap	Other Than Temporary Impairment Credit Losses Recognized In Earnings Credit Losses On Debt Securities Held OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCreditLossesOnDebtSecuritiesHeld	173000	USD
CY2021Q1	us-gaap	Available For Sale Securities Amortized Cost AvailableForSaleSecuritiesAmortizedCost	2200000	USD
CY2021Q1	us-gaap	Impaired Financing Receivable Recorded Investment ImpairedFinancingReceivableRecordedInvestment	12200000	USD
CY2021Q1	us-gaap	Impaired Financing Receivable Related Allowance ImpairedFinancingReceivableRelatedAllowance	1900000	USD
CY2021Q1	nwin	Impaired Financing Receivable Fair Value ImpairedFinancingReceivableFairValue	10300000	USD
CY2020Q4	us-gaap	Impaired Financing Receivable Recorded Investment ImpairedFinancingReceivableRecordedInvestment	11800000	USD
CY2020Q4	us-gaap	Impaired Financing Receivable Related Allowance ImpairedFinancingReceivableRelatedAllowance	1800000	USD
CY2020Q4	nwin	Impaired Financing Receivable Fair Value ImpairedFinancingReceivableFairValue	10000000.0	USD

Files In Submission

Name	View Source	Status
0001437749-21-011347-index-headers.html	Edgar Link	pending
0001437749-21-011347-index.html	Edgar Link	pending
0001437749-21-011347.txt	Edgar Link	pending
0001437749-21-011347-xbrl.zip	Edgar Link	pending
ex_245747.htm	Edgar Link	pending
ex_245748.htm	Edgar Link	pending
ex_245749.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
nwin-20210331.xsd	Edgar Link	pending
nwin-20210331_cal.xml	Edgar Link	unprocessable
nwin-20210331_def.xml	Edgar Link	unprocessable
nwin-20210331_lab.xml	Edgar Link	unprocessable
nwin-20210331_pre.xml	Edgar Link	unprocessable
nwin20210331_10q.htm	Edgar Link	pending
nwin20210331_10q_htm.xml	Edgar Link	completed
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$FNWD
Finward Bancorp Stock $fnwd

2021 Q1 Form 10-Q Financial Statement

#000143774921011347 Filed on May 07, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$FNWD Finward Bancorp Stock $fnwd

2021 Q1 Form 10-Q Financial Statement

#000143774921011347 Filed on May 07, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$FNWD
Finward Bancorp Stock $fnwd